Bruno Oliveira Souza e Silva | Diagnostic | Best Innovation Award

Mr. Bruno Oliveira Souza e Silva | Diagnostic | Best Innovation Award 

Public servant | State Secretariat of Health of Minas Gerais | Brazil

Bruno Oliveira Souza e Silva is a dedicated Brazilian pharmacist and health professional with extensive experience in clinical analysis, laboratory coordination, and public health. He holds a Bachelor’s degree in Pharmacy with specialization in Clinical and Toxicological Analysis from the José do Rosário Vellano University, a Master’s degree in Health Education from UFVJM, and multiple postgraduate specializations in Chemistry, Higher Education Teaching, Environmental Health Surveillance, and Health Surveillance. Currently serving as a Clinical Analyst Pharmacist at the State Health Secretariat of Minas Gerais, he coordinates the Macrorregional Laboratory of Teófilo Otoni, overseeing diagnostic services for tuberculosis, leishmaniasis, and leprosy. His professional background also includes teaching roles at the Doctum University Center of Teófilo Otoni, where he contributes to Pharmacy, Dentistry, Nursing, and Biomedical programs. An alumnus of the EpiSUS Fundamental Program, he is also a Field Epidemiologist and member of the Technical Working Group on Clinical and Toxicological Analysis of the Regional Pharmacy Council of Minas Gerais. Bruno’s expertise spans pharmacy, biochemistry, microbiology, parasitology, and pharmacology, supported by a robust record of research and publication in disease surveillance, epidemiology, and laboratory science. His commitment to innovation and public health excellence has earned him several distinctions, including the Pharmaceutical Attitude Award (2024) and the Inova Minas Gerais Award (2021) for public policy innovation. Passionate about scientific education and health system strengthening, he continues to advance integrated approaches to laboratory diagnostics, disease prevention, and epidemiological surveillance in Brazil’s public health sector.

Profile: ORCID

Featured Publications

Tokai, B. O., & Costa, A. S. (2021). Estudo sobre a qualidade da água para consumo humano e as doenças diarreicas no Brasil. Revista Baiana de Saúde Pública, 43(4), e2979. Cited by: 3

 

Liancai Mu | Diagnostic | Best Researcher Award

Prof. Liancai Mu | Diagnostic | Best Researcher Award

Senior Scientist | Hackensack Meridian Health | United States

Prof. Liancai Mu, M.D., Ph.D., is a Senior Scientist at the Upper Airway Research Laboratory, Center for Discovery & Innovation, Hackensack Meridian Health, with over three decades of academic and clinical experience in otolaryngology and neuroscience. His research focuses on the neuromuscular specializations of human upper airway structures and the mechanisms underlying speech, swallowing, and voice (SSV) disorders, particularly in Parkinson’s disease (PD). Mu’s pioneering work demonstrated that PD affects the peripheral nervous system of the pharynx and larynx, contributing significantly to SSV impairments, and led to the development of novel diagnostic and therapeutic approaches. He mapped the nerve supply of laryngeal, pharyngeal, soft palate, and tongue muscles using Sihler’s staining technique and identified neuromuscular compartments with specialized fibers, leading to a new theory that pharyngeal constrictors are controlled by two distinct neuromuscular systems (IX-SIL and X-FOL), now included in modern medical texts. Additionally, he developed an innovative muscle reinnervation method, “nerve-muscle-endplate grafting” (NMEG), which achieves superior functional recovery compared to traditional nerve repair. Mu has led multiple NIH R01, DOD, and Michael J. Fox Foundation-funded projects, collaborated internationally with institutions such as Mount Sinai Medical Center, Linguaflex, Inc., and the Arizona Study of Aging and Neurodegenerative Disorders, and served as a consultant for FDA-approved therapies. He has published 68 peer-reviewed articles across 22 indexed journals, accrued 2,772 citations and holds an h-index of 30, reflecting his substantial impact in neuroscience, otolaryngology, and PD research.

Profile:  Scopus

Featured Publications

Sadiq Azam | Clinical Microbiology | Best Researcher Award

Assoc. Prof. Dr. Sadiq Azam | Clinical Microbiology | Best Researcher Award

Associate Professor at University of Peshawsar, Pakistan

Dr. Sadiq Azam is an accomplished Associate Professor at the University of Peshawar, specializing in microbiology and biotechnology. With over a decade of academic and research experience, he has significantly contributed to understanding antibiotic resistance in pathogenic bacteria and the antimicrobial properties of medicinal plants. Dr. Azam began his academic career at Bacha Khan University and soon joined the University of Peshawar, where he has progressed through various academic ranks. His research includes several completed projects funded by the Higher Education Commission (HEC) and the Directorate of Science and Technology (DoST), focusing on bacteriological profiling, phytochemical analysis, and molecular characterization of drug-resistant pathogens. A certified supervisor, he has mentored numerous M.Phil, PhD, and undergraduate students. He is an active member of academic boards across various institutions and plays a vital role in curriculum development, examination coordination, and teaching innovation. Dr. Azam is fluent in English, Urdu, and Pashto.

Professional Profiles

Scopus

Education 

Dr. Sadiq Azam earned his PhD in Biotechnology from the University of Peshawar, where he had also completed his Bachelor’s in Biotechnology. Prior to his university education, he studied pre-medical sciences at Nisar Shaheed Degree College, Resalpur. His academic journey began with a foundation in science at Government High School, Swabi. Throughout his education, he focused on understanding biological systems and laboratory methodologies, which laid the groundwork for his later research in antimicrobial resistance, pathogenic microorganisms, and medicinal plant compounds. His doctoral work, supported by a prestigious HEC Indigenous Scholarship, marked the beginning of a research career centered on the intersection of microbiology, molecular biology, and pharmacognosy. The academic rigor and scientific training received throughout his education have shaped his multifaceted expertise in clinical microbiology and applied biotechnology. His educational foundation continues to support his teaching, research supervision, and grant-funded investigations in Pakistan’s higher education and health sectors.

Experience 

Dr. Azam’s professional journey began in 2011 as Assistant Professor at Bacha Khan University, Charsadda. He joined the University of Peshawar, where he advanced from Lecturer to Assistant Professor and now serves as an Associate Professor in the Centre for Biotechnology and Microbiology. With over 13 years of teaching and research experience, he has been involved in undergraduate and postgraduate education, thesis supervision, and lab-based training. Beyond teaching, he has led and collaborated on national research projects focused on phytochemical screening and antibiotic resistance. Dr. Azam has played active administrative roles, including BS program coordination and examination management. He is also a member of several Boards of Studies across universities in Khyber Pakhtunkhwa, contributing to academic planning and quality assurance. His career highlights a balance of academic instruction, impactful research, institutional service, and mentorship in the fields of microbiology, biotechnology, and infectious disease research.

Awards and Honors 

Dr. Sadiq Azam was awarded the prestigious HEC Indigenous Scholarship for his M.Phil to PhD studies, recognizing his academic excellence and potential in scientific research. This scholarship provided vital support for his doctoral work in biotechnology at the University of Peshawar and laid the foundation for a research career focused on combating antimicrobial resistance and exploring plant-based therapeutic alternatives. In addition to academic funding, Dr. Azam has successfully secured competitive research grants from Pakistan’s Higher Education Commission (HEC) and the Directorate of Science and Technology (DoST). These projects, as both Principal and Co-Principal Investigator, reflect national recognition of his expertise and contributions. His continued involvement in funded research projects underscores his credibility and leadership in the scientific community. His honors not only represent personal achievements but also contribute to the growth of biotechnology research capacity in Pakistan. He remains committed to advancing microbiological science through innovation and collaboration.

Research Focus 

Dr. Sadiq Azam’s research centers on bacteriological profiling, molecular genetics of antibiotic resistance, and the pharmacological evaluation of medicinal plants. His primary focus is the identification of resistance genes in clinical isolates, including extended-spectrum β-lactamase (ESBL) and carbapenemase-producing Escherichia coli and Klebsiella pneumoniae. He employs molecular characterization techniques such as PCR, MIC testing, analytical profiling, and in-silico drug design to combat emerging bacterial threats. A parallel area of interest lies in the bioassay screening and phytochemical analysis of traditional medicinal plants like Silene conoidea, Sarcococca saligna, and Pinus wallichiana, aiming to discover novel antimicrobial compounds. His integrated approach bridges clinical microbiology with natural product chemistry, addressing global challenges in antibiotic resistance and infectious disease management. Through research supervision and project leadership, he actively contributes to building Pakistan’s research capacity in biotechnology, while aligning with global health priorities on antimicrobial stewardship and sustainable therapeutics.

Publication Top Notes

Title: Design and Validation of a Polyunit Epitope Vaccine Against Enterococcus faecium
Journal: Journal of Computational Biophysics and Chemistry
Summary:
This study likely focuses on the computational design and validation of a multi-epitope subunit vaccine targeting E. faecium, a notorious multidrug-resistant pathogen. The vaccine design may have used immunoinformatics tools to identify epitopes and predict immunogenicity.

Title: Towards Precision Epitopes Based Vaccine Against Enterococcus faecalis by Integrating Vaccinomics, Reverse Vaccinology and Biophysics Approaches
Journal: Biochemistry and Biophysics Reports
Summary:
The paper integrates vaccinomics and reverse vaccinology to identify precision epitopes for a vaccine targeting E. faecalis. It likely combines computational prediction, immunological profiling, and structural biophysics to develop a targeted vaccine strategy.

Title: Current Pattern of Antibiotic Resistance and Molecular Characterization of Virulence Genes in Klebsiella pneumoniae Obtained from Urinary Tract Infection (UTIs) Patients, Peshawar
Journal: PLOS ONE
Summary:
This research investigates antibiotic resistance patterns and the genetic basis of virulence in K. pneumoniae strains isolated from UTI patients in Peshawar. Likely includes PCR-based detection of virulence genes and antibiotic susceptibility profiling.

Title: Elucidating the Resistance Mechanisms and Binding Pattern of Novel Oxa-48-like Carbapenemases Covalent Inhibitors: A Hybrid Experimental and In Silico Approach
Journal: Journal of Molecular Structure
Summary:
The article explores how novel covalent inhibitors interact with Oxa-48-like carbapenemases—enzymes that confer resistance to carbapenem antibiotics. Uses both computational modeling and experimental data to understand resistance and inhibitor design.

Title: Green Synthesis and Characterisation of Desmodium podocarpum-Mediated Silver Nanoparticles and Their Biological Activities
Journal: Natural Product Research
Summary:
Focuses on the eco-friendly synthesis of silver nanoparticles using Desmodium podocarpum plant extract. Likely includes characterization (UV-Vis, SEM, FTIR) and evaluation of antimicrobial or antioxidant properties.

Conclusion 

Dr. Sadiq Azam stands as a leading academic and researcher in Pakistan’s biotechnology and microbiology landscape. His multidisciplinary expertise combines molecular microbiology, antimicrobial resistance research, and natural product pharmacology. With a strong academic foundation and over a decade of professional experience, he has contributed significantly to both science and education through impactful research, project leadership, and student mentorship. His work aligns with urgent global health issues such as drug-resistant infections and the search for alternative therapies. He has successfully led nationally funded projects and fostered collaborations across institutions. As an educator, Dr. Azam is deeply engaged in curriculum design, teaching innovation, and research supervision, shaping the next generation of scientists. His fluency in English, Urdu, and Pashto enables effective communication and outreach across diverse academic and community settings. Dr. Azam exemplifies the role of a dedicated researcher and educator committed to scientific advancement, public health improvement, and academic excellence in Pakistan.